Bath & Body Works, INC Form 4 insider transactions
NYSE
Alessandro Bogliolo, a Director at Bath & Body Works, Inc. (BBWI), was granted 5,641 shares of common stock as part of an annual restricted stock unit award.
NYSE
Form 4: Bath & Body Works Chief Legal Officer Increases Stake Through Performance Stock Unit Vesting
Bath & Body Works' Chief Legal Officer, Michael C. Wu, increased his direct beneficial ownership of common stock by a net of 3,907 shares following the vesting of performance stock units.
NYSE
Form 4: Bath & Body Works Chief Legal Officer Increases Stake Through Performance Stock Unit Vesting
Bath & Body Works' Chief Legal Officer, Michael C. Wu, increased his direct beneficial ownership of common stock by a net of 3,907 shares following the vesting of performance stock units.
NYSE
Thomas E. Mazurek, Chief Supply Chain Officer at Bath & Body Works, Inc., reported the acquisition of shares from performance unit vesting and subsequent disposition for tax obligations.
NYSE
Bath & Body Works, Inc. CEO Daniel Heaf was granted 82,590 restricted stock units, aligning his interests with long-term shareholder value.
NYSE
Michael C. Wu, Chief Legal Officer & Corp Secy of Bath & Body Works, reports disposition of shares to cover tax obligations related to vesting of restricted stock units.
NYSE
Thomas E. Mazurek, Chief Supply Chain Officer of Bath & Body Works, sold 1,693 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.
NYSE
Michael C. Wu, Chief Legal Officer & Corp Secy of Bath & Body Works, files an amended Form 4/A to correct an error in a previously filed Form 4 regarding the vesting of performance stock units.
NYSE
Thomas E. Mazurek, Chief Supply Chain Officer at Bath & Body Works, files an amended Form 4/A to correct an error in a previous filing regarding the vesting of performance stock units.
NYSE
Michael C. Wu, Chief Legal Officer & Corp Secy of Bath & Body Works, reports acquisition of shares and disposition of shares to cover tax obligations.
NYSE
Thomas Mazurek, Chief Supply Chain Officer of Bath & Body Works, reports the acquisition and disposal of company stock.
NYSE
Gina Boswell, CEO of Bath & Body Works, reports acquiring and disposing of company stock.
NYSE
Chief Financial Officer Eva Boratto reports acquisition and disposal of Bath & Body Works, Inc. shares.
NYSE
Director Sarah E. Nash reported the acquisition of 127,288 shares of common stock through stock unit conversion and the disposition of 16,776 shares to cover tax obligations.
NYSE
Michael C. Wu, Chief Legal Officer & Corp Secy of Bath & Body Works, reports acquisition and disposal of company stock on March 9, 2025.
NYSE
Chief Supply Chain Officer Thomas Mazurek reports acquisition and disposal of Bath & Body Works (BBWI) common stock on March 9, 2025.
NYSE
Michael C. Wu, Chief Legal Officer & Corp Secy of Bath & Body Works, files an amended SEC Form 4 to correct the number of shares withheld for tax purposes.
NYSE
Thomas Mazurek, Chief Supply Chain Officer at Bath & Body Works, amends a previous SEC Form 4 filing to correct the number of shares withheld for tax purposes.
NYSE
Bath & Body Works CEO, Gina Boswell, sold 12,577 shares of common stock to cover tax obligations related to vesting equity.
NYSE
A Bath & Body Works executive, Thomas E. Mazurek, sold 2,200 shares of common stock at $31.45 per share on November 18, 2024.
NYSE
Bath & Body Works CEO Gina Boswell recently purchased 6,000 shares of the company's common stock at an average price of $29.642.
NYSE
Michael C. Wu, Chief Legal Officer & Corp Secy of Bath & Body Works, disposed of 459 shares of common stock on August 18, 2024, to cover tax obligations.
NYSE
Julie Rosen, President of Retail at Bath & Body Works, reported a transaction involving the disposition of company stock to cover tax obligations.
NYSE
Deon Riley, Chief Human Resources Officer at Bath & Body Works, reports the disposition of 1,221 shares of common stock to cover tax obligations.
NYSE
Eva Boratto, CFO of Bath & Body Works, disposed of 6,997 shares of common stock on August 1, 2024, at a price of $35.13 per share.
NYSE
Director Steven E. Voskuil acquired 3,844 shares of Bath & Body Works, Inc. common stock on June 27, 2024.
NYSE
Director James Kevin Symancyk reports changes in beneficial ownership of Bath & Body Works, Inc. shares, including acquisition and disposal.
NYSE
Director Stephen Steinour acquired 3,844 shares of Bath & Body Works, Inc. common stock on June 27, 2024.
NYSE
Director Juan Rajlin reports a transaction involving Bath & Body Works, Inc. common stock on June 27, 2024.
NYSE
Director Sarah E. Nash acquired 6,406 shares of Bath & Body Works, Inc. common stock on June 27, 2024.